DIFFERENTIATION BETWEEN MK-801-INDUCED AND APOMORPHINE-INDUCED STEREOTYPED BEHAVIORS IN MICE

The ability of phencyclidine (PCP) to model schizophreniform psychosis is believed to be related to its ability to produce both hypoglutamatergia and hyperdopaminergia. As such, identification of PCP-stimulated behaviors may be important for the development of animal models of schizophrenia. In this study, MK-801 {(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycloheptane-5,10-imine maleate}, a high-affinity PCP analogue, was administered to mice in order to stimulate ''PCP behaviors.'' These PCP behaviors were compared with behaviors stimulated by apomorphine, a dopamine agonist. Stereotyped behavior was assessed by both visual observations and automated measurements. Visual observations showed highly intense gnawing and sniffing in apomorphine-treated mice and the absence of gnawing in MK-801-treated mice. Automated stereotypic measures showed that, compared with vehicle-treated controls, there were frequent dissociations between MK-801 and apomorphine. Conceivably, a compound that attenuates PCP-stimulated behaviors while sparing apomorphine-stimulated behaviors would possess both antipsychotic efficacy and be devoid of undesirable side effects associated with dopamine blockade.